Author: Julio Gil Onandia

Healthy volunteer trial looking at pharmacokinetics of TXA in alternate routes, shows IM TXA to be an efficient alternative to IV
January 7, 2022 Uncategorized Julio Gil Onandia

Background: In response to the World Health Organization call for research on alternative routes for tranexamic acid(TXA) administration in women with postpartum haemorrhage, we examined the pharmacokinetics of TXA after i.v., i.m., or oral administration.Methods: We conducted a randomised, open-label, crossover trial in 15 healthy volunteers who received i.v. TXA 1 g, i.m. TXA 1

Details